These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34761195)

  • 1. Perampanel during pregnancy: Description of four cases.
    Alicino AM; Falcicchio G; Boero G; Santarcangelo G; Francavilla T; Trojano M; La Neve A
    Epilepsy Behav Rep; 2021; 16():100490. PubMed ID: 34761195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures.
    Fogarasi A; Flamini R; Milh M; Phillips S; Yoshitomi S; Patten A; Takase T; Laurenza A; Ngo LY
    Epilepsia; 2020 Jan; 61(1):125-137. PubMed ID: 31912493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures.
    Tyrlikova I; Brazdil M; Rektor I; Tyrlik M
    Expert Rev Neurother; 2019 Jan; 19(1):5-16. PubMed ID: 30560703
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
    Rektor I; Krauss GL; Inoue Y; Kaneko S; Williams B; Patten A; Malhotra M; Laurenza A; Wechsler RT
    Epilepsia; 2020 Jul; 61(7):1491-1502. PubMed ID: 32645213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry.
    Toledano Delgado R; García-Morales I; Parejo-Carbonell B; Jiménez-Huete A; Herrera-Ramirez D; González-Hernández A; Ayuga Loro F; Santamarina E; Toledo M; Ojeda J; Poza JJ; Molins A; Giner P; Estévez María JC; Castro-Vilanova MD; Zurita J; Saiz-Diaz RA; Gómez-Ibañez A; Rodriguez-Uranga J; Gil-Nagel A; Campos D; Sánchez-Larsen Á; Aguilar-Amat Prior MJ; Mauri Llerda JA; Huertas González N; García-Barragán N
    Epilepsia; 2020 Jun; 61(6):1109-1119. PubMed ID: 32511754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.
    Villanueva V; Montoya J; Castillo A; Mauri-Llerda JÁ; Giner P; López-González FJ; Piera A; Villanueva-Hernández P; Bertol V; Garcia-Escrivá A; Garcia-Peñas JJ; Garamendi I; Esteve-Belloch P; Baiges-Octavio JJ; Miró J; Falip M; Garcés M; Gómez A; Gil-López FJ; Carreño M; Rodriguez-Uranga JJ; Campos D; Bonet M; Querol R; Molins A; Tortosa D; Salas-Puig J
    Epilepsia; 2018 Sep; 59(9):1740-1752. PubMed ID: 30062784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studies.
    Kwan P; Mintzer S; Laurenza A; Patten A; Cartwright K
    Epilepsy Behav Case Rep; 2018; 9():1-5. PubMed ID: 29707476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies.
    Piña-Garza JE; Rosenfeld W; Saeki K; Villanueva V; Yoshinaga H; Patten A; Williams B; Malhotra M
    Epilepsy Behav; 2020 Mar; 104(Pt A):106876. PubMed ID: 31954998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: A single-center postmarketing study.
    Singh K; Shah YD; Luciano D; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Aug; 61():41-45. PubMed ID: 27300147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.
    Steinhoff BJ; Patten A; Williams B; Malhotra M
    Epilepsia; 2020 Feb; 61(2):278-286. PubMed ID: 31944276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perampanel in lissencephaly-associated epilepsy.
    Ikemoto S; Hamano SI; Hirata Y; Matsuura R; Koichihara R
    Epilepsy Behav Case Rep; 2019; 11():67-69. PubMed ID: 30723672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perampanel: A Review in Drug-Resistant Epilepsy.
    Frampton JE
    Drugs; 2015 Sep; 75(14):1657-68. PubMed ID: 26370209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).
    Abril Jaramillo J; Estévez María JC; Girón Úbeda JM; Vega López Ó; Calzado Rivas ME; Pérez Díaz H; García Martín G; Vila Herrero E; Chamorro-Muñoz M; Vázquez F; De la Fuente C; Redondo L; Peláez N; Santágueda P; Rodríguez Uranga JJ
    Epilepsy Behav; 2020 Jan; 102():106655. PubMed ID: 31812902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a "real world" context: focus on temporal lobe epilepsy.
    Pascarella A; Iannone LF; Di Gennaro G; D'Aniello A; Ferlazzo E; Gagliostro N; Ursini F; Bonanni P; Paciello N; Romigi A; Aguglia U; De Sarro G; Russo E; Gambardella A; Labate A
    J Neurol Sci; 2020 Aug; 415():116903. PubMed ID: 32447055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First add-on perampanel for focal-onset seizures: An open-label, prospective study.
    Kim JH; Kim DW; Lee SK; Seo DW; Lee JW; Park HJ; Lee SA
    Acta Neurol Scand; 2020 Feb; 141(2):132-140. PubMed ID: 31745975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
    Tudur Smith C; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2001; (4):CD001769. PubMed ID: 11687121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry.
    Battino D; Tomson T; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Epilepsia; 2013 Sep; 54(9):1621-7. PubMed ID: 23848605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease).
    Schorlemmer K; Bauer S; Belke M; Hermsen A; Klein KM; Reif PS; Oertel WH; Kunz WS; Knake S; Rosenow F; Strzelczyk A
    Epilepsy Behav Case Rep; 2013; 1():118-21. PubMed ID: 25667843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study.
    Zhang R; Qiao S; Fang X; Wang K; Shi Y; Du Q; Yang T; Liu X
    Front Neurol; 2021; 12():731566. PubMed ID: 34526963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.